Aleksandar Skuban
Aleksandar Skuban publishes mostly in Pharmacology, Psychiatry and Mental health and Economics and Econometrics, on topics such as Treatment of Major Depression, Schizophrenia research and treatment and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #1,210,751 of 7,710,434 ranked researchers
- Rank in Denmark
- #9,112 of 43,819
- Works
- 23
- Citations
- 1.2k
- Citations per work
- 53.2
What does Aleksandar Skuban research?
Aleksandar Skuban's work is mostly in Medicine (50%), Economics, Econometrics and Finance (12%), Neuroscience (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1250.0%
- Medicine1250.0%
- Social Sciences521.4%
- Everything else519.7%
- Life Sciences28.9%
- Neuroscience28.9%
- 1Pharmacology27% of their works
- 2Psychiatry and Mental health20% of their works
- 3Economics and Econometrics12% of their works
- 4Cellular and Molecular Neuroscience9% of their works
- 5Clinical Psychology9% of their works
- 6Pediatrics, Perinatology and Child Health4% of their works
Research topics
- Treatment of Major Depression
- Schizophrenia research and treatment
- Health Systems, Economic Evaluations, Quality of Life
- Neurotransmitter Receptor Influence on Behavior
- Psychotherapy Techniques and Applications
- Cardiac electrophysiology and arrhythmias
- Pharmaceutical studies and practices
- Pharmacological Receptor Mechanisms and Effects
Which keywords describe Aleksandar Skuban's research?
The keywords of their largest research topics: Antidepressant, Depression, Antipsychotic Drugs, Neurocognitive Deficits, Cost-effectiveness Analysis, Quality of Life, Dopamine and Serotonin.
- Chaperone
- Off-Label Drug Use
- Arrhythmias
- Therapeutic Alliance
- Serotonin
- Quality of Life
- Neurocognitive Deficits
- Depression
- Antidepressant
- Antipsychotic Drugs
- Cost-effectiveness Analysis
- Dopamine
- Psychotherapy Outcome
- Calcium Signaling
- Long-QT Syndrome
- Pediatric Pharmacokinetics
- Sigma-1 Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antidepressant141 topic
- Depression141 topic
- Antipsychotic Drugs81 topic
- Neurocognitive Deficits81 topic
- Cost-effectiveness Analysis71 topic
- Quality of Life71 topic
- Dopamine51 topic
- Serotonin51 topic
- Psychotherapy Outcome41 topic
- Therapeutic Alliance41 topic
- Calcium Signaling32 topics
- Arrhythmias21 topic
- Long-QT Syndrome21 topic
- Off-Label Drug Use21 topic
- Pediatric Pharmacokinetics21 topic
- Chaperone11 topic
- Sigma-1 Receptor11 topic
Where does Aleksandar Skuban work?
Aleksandar Skuban's main affiliation in the publication record is Lundbeck (Denmark), Denmark.
How many publications and citations does Aleksandar Skuban have?
OpenAlex counts 23 works and 1,223 citations for Aleksandar Skuban, an h-index of 12, ranking #1,210,751 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Aleksandar Skuban. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.